By: Karen Chen, PharmD Candidate c/o 2019 On July 13th, 2018, the U.S. Food and Drug Administration (FDA) announced a voluntary recall of several different national drug codes (NDCs) of medications containing the active ingredient valsartan (Diovan®) after the discovery of an impurity called N-nitrosodimethylamine (NDMA). The reason for the recall was because the impurity…

By: Michael Lim, PharmD Candidate c/o 2020 As the nation continues to struggle with the growing opioid epidemic, numerous organizations, researchers, and even the president are taking initiative in resolving the crisis. Of these groups, perhaps one of the most proactive in its efforts is the Food and Drug Administration (FDA). With its promotion of…

By: Shivani Shah, PharmD Candidate c/o 2021 Medication therapy management (MTM) is a service provided by pharmacists to eligible patients who participate in a Medicare drug plan, namely part D. The geriatric population, which is included among the aforementioned eligible patients, is prone to taking numerous medications as they tend to have multiple disease states…